載入...
Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
Personalized cell therapy targeting tumor antigens with expanded tumor-infiltrating lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s. However, MM was first-in line to benefit from the wave of checkpoint inhibitors (CPI), which shifted the focus of immunotherapy al...
Na minha lista:
| 發表在: | J Immunother Cancer |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7398110/ https://ncbi.nlm.nih.gov/pubmed/32747469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000668 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|